PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Unicycive Therapeutics, Inc.
Filed: April 16, 2024
Period of Report: April 16, 2024
Accession Number: 0001213900-24-033430

View Document ↗ View on SEC.gov ↗